Drug survival of anti-tumour necrosis factor α therapy in spondyloarthropathies: results from the Spanish emAR II Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug survival of anti-tumour necrosis factor α therapy in spondyloarthropathies: results from the Spanish emAR II Study

Published:2015-03-12 Issue:8 Volume:54 Page:1459-1463
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Rosales-Alexander José Luis,Balsalobre Aznar Jerónimo,Pérez-Vicente Sabina,Magro-Checa César

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/54/8/1459/5092076/kev001.pdf

Reference20 articles.

1. Akkoc N Khan MA . Epidemiology of ankylosing spondylitis and related spondyloarthropathies. In: Weisman MH Reveille JD van der Heijde D , editors. Ankylosing Spondylitis and the Spondyloarthropathies: A Companion to Rheumatology. London, UK: Mosby-Elsevier; 2006. p. 117-31.

2. Rheumatology in italy

3. Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

4. Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression

5. Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: Results of a fifty-four–week study

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network;Scientific Reports;2024-01-16

2. Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study;Advances in Therapy;2021-09-03

3. Sex-based differences in inflammatory bowel diseases: a review;Therapeutic Advances in Gastroenterology;2020-01

4. Factors associated with ASDAS remission in a long-term study of ankylosing spondylitis patients under tumor necrosis factor inhibitors;Advances in Rheumatology;2018-12

5. Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry;Rheumatology and Therapy;2018-10-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3